Recreational drug use in Kenya

BioXcel Therapeutics Announces Update on NIDA-funded Trial of BXCL501 (sublingual dexmedetomidine) for Potential Treatment of Opioid Use Disorder (OUD)

Retrieved on: 
月曜日, 11月 6, 2023
Post-traumatic stress disorder, FDA, Yale School of Medicine, Opioid use disorder, Standard of care, Intelligence, Government, Public Health Service Act, White House, Dexmedetomidine, Opioid epidemic, BID, Federal Food, Drug, and Cosmetic Act, Federation, Addiction, Xylazine, Psychiatry, COWS, Recreational drug use in Kenya, Locus coeruleus, Pharmacokinetics, OUD, National Institute on Drug Abuse, NIDA, Columbia University, NIH, Safety, Public, American Journal, Minneapolis Veterans Affairs Health Care System, Therapy, Office of Inspector General, U.S. Department of Health and Human Services, Patient, Fentanyl, Bangladesh Technical Education Board, RTI International, United States Public Health Service, Pharmaceutical industry, Neuroscience

NEW HAVEN, Conn., Nov. 06, 2023 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced an update on the National Institute on Drug Abuse (NIDA)-funded trial evaluating BXCL501 (sublingual dexmedetomidine) as a potential treatment for opioid use disorder (OUD).

Key Points: 
  • NIDA has requested Columbia University, the trial coordinator, to add a fourth site to target trial completion in 2024.
  • After this time, BioXcel Therapeutics plans to seek FDA feedback on potential registrational paths.
  • “With BXCL501, we are excited about the potential to treat patients who are physically dependent on illicit and prescription opioids.
  • In addition to OUD as an indication, BioXcel Therapeutics has been awarded key opportunities for the development of BXCL501 in post-traumatic stress disorder and alcohol use disorder.

Charlotte's Web Reports 2023 First Quarter Financial Results

Retrieved on: 
金曜日, 5月 12, 2023
Charlotte's Web, BAT, Pressure, LSE, The Vitamin Shoppe, Wine & Spirits, Genetics, NSF, Southern Glazer's Wine and Spirits, Food, Meijer, DSM-IV codes, CWEB, Millennials, Entity, Recreational drug use in Kenya, Athlete, Dietary supplement, Natural American Spirit, MLB, Sport, TSX, FDA, Richard Genzer, Press release, Regulation of tobacco by the U.S. Food and Drug Administration, Mental health, American Tobacco Company, NYSE, BTI, Pharmaceutical industry, CBD

LOUISVILLE, Colo., May 12, 2023 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2023.

Key Points: 
  • LOUISVILLE, Colo., May 12, 2023 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2023.
  • "In the first quarter, we maintained prudent cost controls to balance softness in the CBD category due to the unregulated environment.
  • We successfully reduced operating expenses by 14% on a year-over-year basis and ended the first quarter with a cash balance of $61 million.
  • "On the regulatory front we were encouraged during the quarter by increased activity in Washington, D.C. including the reintroduction of bill H.R.

PodMatch Does Something Most Software Companies Would Consider Crazy, But It's Paying Off In A Big Way

Retrieved on: 
月曜日, 10月 10, 2022
Software, Time, Industry, Database, Health, Sanfilippo, Social media, Growth, Recreational drug use in Kenya, Cryptocurrency, Risk management

JACKSONVILLE, Fla., Oct. 10, 2022 /PRNewswire/ -- PodMatch.com, a podcast booking service that automatically matches ideal podcast guests and hosts together to record high-quality podcast interviews, has just completed a massive purge of its userbase. They removed just under 12,320 accounts from the platform that were inactive podcast shows, low-quality/spammy guest users, or accounts with multiple abuse reports against them. PodMatch did this to ensure that the platform remains of the highest possible quality for the members that are using the software regularly.

Key Points: 
  • PodMatch did this to ensure that the platform remains of the highest possible quality for the members that are using the software regularly.
  • When asked about this bold move, Alex Sanfilippo, founder of PodMatch, said,"Most podcasting software companies fight to obtain or maintain the highest number of top-line users.
  • But the reality of the industry is that 90% of people who start a podcast stop within their first 365 days.
  • PodMatch Members check the status of your account by logging into: https://PodMatch.com/dash (Recreate your account if you cannot login)